NCT03410212View on ClinicalTrials.gov

Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

July 15, 2018

Study Completion Date

November 15, 2018

Conditions
Symptomatic Irreversible Pulpitis
Interventions
DRUG

Ketorolac Tromethamine

The 30mg/mL vial of Ketorolac will be injected as second inferior alveolar nerve block and the success of anesthesia will be evaluated using visual analog scale.

BEHAVIORAL

Sham injection

In the control group, the sham injection will be provided at the same place of the first inferior alveolar nerve block but any injection would be done.

Trial Locations (1)

Unknown

Dental Branch, AZad UMS, Tehran

All Listed Sponsors
lead

Azad University of Medical Sciences

OTHER

NCT03410212 - Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain | Biotech Hunter | Biotech Hunter